Carl B Ziegler, Jr

Title: Carl B Ziegler, Jr: Innovator in Pharmaceutical Chemistry

Introduction

Carl B Ziegler, Jr. is a notable inventor based in Congers, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of piperazine derivatives. With a total of 2 patents, Ziegler's work has had a meaningful impact on the treatment of bacterial infections in warm-blooded animals.

Latest Patents

Ziegler's latest patents include innovative compounds such as 7-(substituted)piperazinyl-1-ethyl-6-fluoro-4-oxo-3-quinolinecarboxylic acids and their pharmacologically acceptable salts. These patents also cover compositions containing these compounds, processes and intermediates for producing them, and methods of using them to treat bacterial infections. His work in this area demonstrates a commitment to advancing medical treatments and improving health outcomes.

Career Highlights

Throughout his career, Ziegler has been associated with the American Cyanamid Company, where he has contributed to various research initiatives. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the development of new therapeutic agents.

Collaborations

Ziegler has collaborated with notable colleagues such as Phaik-Eng Sum and Joseph P Joseph. These partnerships have fostered innovation and have been instrumental in the advancement of their shared research goals.

Conclusion

Carl B Ziegler, Jr. is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the field. His patents and collaborations reflect a dedication to improving medical treatments and addressing critical health challenges.